"Con 85 años de trayectoria, Sanatorio Allende cuenta con más de 50 especialidades, profesionales altamente capacitados y tecnología de vanguardia para el cuidado de tu salud."

During the past decade, Sanatorio Allende conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 23 clinical trials were completed, i.e. on average, 65.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 18 clinical trials were completed. i.e. 105.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sanatorio Allende" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Boehringer Ingelheim" with 5 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 3 trials sponsored and "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanatorio Allende" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Actoverco" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Sanatorio Allende" are "Pulmonary Arterial Hypertension" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Heart Failure" (2 trials) and "Non-small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Sanatorio Allende" in a lesser frequency.

Most popular intervention types in "Sanatorio Allende" are "Drug" (35 trials), "Biological" (5 trials), "Other" (5 trials), "Radiation" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Carboplatin" (3 trials), "Empagliflozin" (3 trials), "Paclitaxel" (3 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sanatorio Allende" are 43 trials for "All" genders.

Currently, there are NaN active trials in "Sanatorio Allende". undefined are not yet recruiting, 11 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Sanatorio Allende, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Sanatorio Allende, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".